Bradley MC, et al. - The association between androgen deprivation therapy (ADT) use and diabetes complications was investigated in prostate cancer patients via a retrospective cohort study among men with newly diagnosed localized prostate cancer between 1995 and 2008, enrolled in three integrated health care systems. Researchers recognized an increased risk of diabetes complications in association with ADT use in men with type II diabetes mellitus who received curative intent therapy for prostate cancer. Findings thereby support that ADT worsens diabetes control.